학술논문
1480P Real-world progression outcomes among patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with liposomal irinotecan-based regimens in the United States
Document Type
Abstract
Author
Source
In Annals of Oncology September 2021 32 Supplement 5:S1092-S1093
Subject
Language
ISSN
0923-7534